business

Novo Nordisk lifts forecasts after strong demand for Wegovy weight-loss pill

Financial Times · May 6, 2026, 7:22 AM · Also reported by 4 other sources

Shares in Danish drugmaker surge on positive signal from results

Read full story on Financial Times → More top stories

Also covered by

MarketWatch Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history. CNBC Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance Investing.com Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares surge Investing.com Novo Nordisk’s Q1 profit beats forecasts

Aggregated and edited by the Scoop newsroom. We surface news from Financial Times alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Novo Nordisk lifts forecasts after strong demand for Wegovy weight-loss pill

Also covered by

More in business